KRRO
Korro Bio, Inc.
$12.28
-0.75 (-5.76%)
At close · Jul 16
Market Cap
$177.11M
Shares
14,422,571
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$12.28
Open$12.94
Day$12.12–13.13
52W$5.20–55.89
Avg vol 30d255K
Short int1.7M · 11.8% float · 4.6d
Short vol79%
Last earningsMay 7, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 7
Up next
Next earnings call
Aug 10, 2026
Est · unconfirmed
· in 3 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Sell
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 16.7 · calm
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−23%
below
Price vs 50-day avg
+0%
above
RSI (14)
44
neutral
MACD trend
Negative
52-week position
14%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+15%
trailing
6-month return
+17%
trailing
YTD return
+53%
this year
Relative strength
+8%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $12 › 200d $16 — 200d above 50d
Institutional flow
Accumulating
4 of 99 funds reported for Jun 30 · net +11.6K sh shares · +1 new
Insider flow
Distributing
Net -$416.1K over 90 days · 100% sells
Short interest
Rising
11.82% of float · ▲ +29.2% MoM · 4.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
99 holders — near 2-yr high, broad support
Squeeze score
70
high risk · 0–100
Fundamentals
Revenue growth
+181%
Y/Y
EPS growth
−33%
Y/Y
Free cash flow
$-79.1M
Balance sheet
$11.6M
net cash
Quant / Vol
risk profile
Volatility
125%
annualized · 1-yr
Max drawdown
−90%
past year
ATR
9.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−23%
Bearish
Price vs 50-day avg
+0%
Bullish
RSI (14)
44
Neutral
MACD trend
Negative
Bearish
52-week position
14%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $12 › 200d $16 — 200d above 50d
Institutional flow
Accumulating
4 of 99 funds reported for Jun 30 · net +11.6K sh shares · +1 new
Insider flow
Distributing
Net -$416.1K over 90 days · 100% sells
Short interest
Rising
11.82% of float · ▲ +29.2% MoM · 4.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
99 holders — near 2-yr high, broad support
Price context
position in its 52-week range
52-wk low $5
Now $12 · 14%
52-wk high $56
vs 200-day avg -23%
vs 50-day avg +0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
KRRO
this stock
Korro Bio, Inc.
|
$177.11M | +53.3% | +181.5% | — | 11.8% |
|
ONC
BeOne Medicines Ltd.
|
$458.76B | +2.5% | +22179.2% | 933.6 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$123.36B | +7.2% | +46.2% | 28.8 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$71.18B | -11.9% | +20.8% | 16.6 | 3.3% |
|
ARGX
Argenx SE
|
$53.68B | +2.0% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| KRRO | -14.1% | +15.2% | +16.8% | -6.8% | +53.3% |
| SPY | -0.1% | +0.1% | +9.0% | +0.5% | +10.1% |
| vs SPY | -14.0% | +15.2% | +7.9% | -7.4% | +43.2% |